Solbar Ningbo Protein Technology Co., Ltd.

SHSE:603231 Voorraadrapport

Marktkapitalisatie: CN¥3.3b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Solbar Ningbo Protein Technology Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Solbar Ningbo Protein Technology has a total shareholder equity of CN¥1.8B and total debt of CN¥23.8M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CN¥2.0B and CN¥186.7M respectively. Solbar Ningbo Protein Technology's EBIT is CN¥140.4M making its interest coverage ratio -23.6. It has cash and short-term investments of CN¥832.4M.

Belangrijke informatie

1.3%

Verhouding schuld/eigen vermogen

CN¥23.77m

Schuld

Rente dekkingsratio-23.6x
ContantCN¥832.41m
AandelenCN¥1.82b
Totaal verplichtingenCN¥186.74m
Totaal activaCN¥2.01b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Solbar Ningbo Protein Technology's (SHSE:603231) Shareholders Have More To Worry About Than Only Soft Earnings

Sep 05
Solbar Ningbo Protein Technology's (SHSE:603231) Shareholders Have More To Worry About Than Only Soft Earnings

Estimating The Intrinsic Value Of Solbar Ningbo Protein Technology Co., Ltd. (SHSE:603231)

Apr 16
Estimating The Intrinsic Value Of Solbar Ningbo Protein Technology Co., Ltd. (SHSE:603231)

Analyse van de financiële positie

Kortlopende schulden: 603231's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥164.8M).

Langlopende schulden: 603231's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥22.0M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 603231 has more cash than its total debt.

Schuld verminderen: Insufficient data to determine if 603231's debt to equity ratio has reduced over the past 5 years.

Schuldendekking: 603231's debt is well covered by operating cash flow (334.7%).

Rentedekking: 603231 earns more interest than it pays, so coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven